By
Adrianne Appel2022-10-20T20:17:00
Seven members of corporate boards resigned after the Antitrust Division of the Department of Justice (DOJ) flagged their situations as potential violations of the Clayton Act.
Assistant Attorney General Jonathan Kanter, head of the Antitrust Division, put companies on notice during a speech delivered in April that he intended to begin ramping up enforcement of Section 8 of the Clayton Act, which prohibits directors and officers from sitting on boards of competing businesses.
The agency warned again in a press release Wednesday the seven resignations were just the first action “in a broader review of potentially unlawful interlocking directorates.”
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2024-04-02T00:04:00Z By Kyle Brasseur
Two directors on the board at media giant Warner Bros. Discovery resigned after the Department of Justice raised antitrust concerns regarding their similar positions on the board of Charter Communications.
2023-03-09T21:13:00Z By Adrianne Appel
Five corporate board members resigned after being flagged by the Department of Justice for potentially violating the antitrust provisions of the Clayton Act.
2023-02-06T19:20:00Z By Adrianne Appel
The Department of Justice announced the withdrawal of three guidance documents related to mergers and antitrust in healthcare, after labeling the policy statements “outdated” and “overly permissive.”
2026-01-22T17:32:00Z By Neil Hodge
Nick Ephgrave, director of the U.K.’s main anti-corruption enforcement agency, the Serious Fraud Office, will retire at the end of March—about halfway through his appointed five-year term. Experts say he leaves the agency in a lot better position than he joined it in September 2023.
2026-01-16T20:32:00Z By Oscar Gonzalez
The U.S. Federal Trade Commission finalized its order against General Motors and its OnStar subsidiary over the improper usage of geolocation and driving behavior data of drivers.
2026-01-16T17:49:00Z By Adrianne Appel
Kaiser Health affiliates have agreed to pay more than $556 million to settle allegations originally made by whistleblowers that they ignored compliance department warnings and unlawfully reworked diagnoses for Medicare patients in order to receive higher payments from the federal government.
Site powered by Webvision Cloud